These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36992247)

  • 21. Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children.
    Pasetti M; Eriksson P; Ferrero F; Manghi M
    Infection; 1997; 25(6):339-45. PubMed ID: 9427051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of reconstitution of an Haemophilus influenzae type b-tentanus toxoid conjugate (PRP-T) vaccine on the immune responses to a diphtheria-tetanus-whole cell pertussis (DTwP) vaccine: a five-year follow-up.
    Hoppenbrouwers K; Roelants M; Ethevenaux C; Vandermeulen C; Knops J; Desmyter J
    Vaccine; 1999 Jun; 17(20-21):2588-98. PubMed ID: 10418907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.
    Martinón-Torres F; Halperin SA; Nolan T; Tapiéro B; Perrett KP; de la Cueva IS; García-Sicilia J; Stranak Z; Vanderkooi OG; Kosina P; Rumlarova S; Virta M; Arribas JMM; Miranda-Valdivieso M; Novas BA; Bozensky J; Ortega MJC; Amador JTR; Baca M; Palomino EE; Zuccotti GV; Janota J; Marchisio PG; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Mesaros N
    Vaccine; 2021 Mar; 39(11):1598-1608. PubMed ID: 33612341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprotection against diphtheria and tetanus among Russian and Norwegian teenagers.
    Danilova E; Shiryayev A; Kristoffersen EK; Sjursen H
    APMIS; 2006 Jun; 114(6):453-7. PubMed ID: 16856968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative tetanus antibody response of Nigerian children to diphtheria-pertussis-tetanus and pentavalent vaccines.
    Uket HO; Ekanem EE; Okpara HC; Ekrikpo UE
    Niger Postgrad Med J; 2018; 25(3):137-142. PubMed ID: 30264763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphtheria- and tetanus-containing vaccination in the last 20 years.
    Dominicus R; Galtier F; Richard P; Baudin M
    Vaccine; 2014 Jun; 32(31):3942-9. PubMed ID: 24852717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A model for developing countries of mass serological survey of children vaccinated against diphtheria and tetanus.
    Nazari F; Mirchamsy H; Alé-Agha S; Mahinpour M
    J Biol Stand; 1976; 4(4):329-35. PubMed ID: 993218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does vaccination ensure protection? Assessing diphtheria and tetanus antibody levels in a population of healthy children: A cross-sectional study.
    Gowin E; Wysocki J; Kałużna E; Świątek-Kościelna B; Wysocka-Leszczyńska J; Michalak M; Januszkiewicz-Lewandowska D
    Medicine (Baltimore); 2016 Dec; 95(49):e5571. PubMed ID: 27930568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
    Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
    Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults.
    Brandon D; Kimmel M; Kuriyakose SO; Kostanyan L; Mesaros N
    Vaccine; 2018 Oct; 36(42):6325-6333. PubMed ID: 30197282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
    Pichichero ME; Blatter MM; Kennedy WA; Hedrick J; Descamps D; Friedland LR
    Pediatrics; 2006 Apr; 117(4):1084-93. PubMed ID: 16585302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Seroimmunity to diphtheria and tetanus among mother-infant pairs; the role of maternal immunity on infant immune response to diphtheria-tetanus vaccination.
    Saffar MJ; Khalilian AR; Ajami A; Saffar H; Qaheri A
    Swiss Med Wkly; 2008 May; 138(17-18):256-60. PubMed ID: 18481231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody persistence after primary and booster doses of a pentavalent vaccine against diphtheria, tetanus, acellular pertussis, inactivated poliovirus, haemophilus influenzae type B vaccine among Thai children at 18-19 months of age.
    Chotpitayasunondh T; Thisyakorn U; Pancharoen C; Chuenkitmongkol S; Ortiz E
    Southeast Asian J Trop Med Public Health; 2012 Mar; 43(2):442-54. PubMed ID: 23082595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunity against diphtheria among children aged 5-17 years in India, 2017-18: a cross-sectional, population-based serosurvey.
    Murhekar MV; Kamaraj P; Kumar MS; Khan SA; Allam RR; Barde PV; Dwibedi B; Kanungo S; Mohan U; Mohanty SS; Roy S; Sagar V; Savargaonkar D; Tandale BV; Topno RK; Kumar CPG; Sabarinathan R; Bitragunta S; Grover GS; Lakshmi PVM; Mishra CM; Sadhukhan P; Sahoo PK; Singh SK; Yadav CP; Kumar R; Dutta S; Toteja GS; Gupta N; Mehendale SM;
    Lancet Infect Dis; 2021 Jun; 21(6):868-875. PubMed ID: 33485469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and safety of the new reduced-dose tetanus-diphtheria vaccine in healthy Korean adolescents: A comparative active control, double-blind, randomized, multicenter phase III study.
    Han SB; Rhim JW; Shin HJ; Kim SY; Kim JH; Kim HH; Lee KY; Kim HM; Choi YY; Ma SH; Kim CS; Kim DH; Ahn DH; Kang JH
    J Microbiol Immunol Infect; 2017 Apr; 50(2):207-213. PubMed ID: 26055693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary immunization with a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian infants: an analysis of antibody response.
    Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Pourheidari F; Ostadkarampour M; Tavangar B; Shokri F
    Iran J Allergy Asthma Immunol; 2009 Jun; 8(2):85-93. PubMed ID: 19671937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunity and immunization of children against diphtheria in Sweden.
    Mark A; Christenson B; Granström M; Strandell A; Wickbom B; Böttiger M
    Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):214-9. PubMed ID: 2496989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of diphtheria and tetanus antibodies among adults in Singapore: a national serological study to identify most susceptible population groups.
    Ang LW; James L; Goh KT
    J Public Health (Oxf); 2016 Mar; 38(1):99-105. PubMed ID: 25678536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity and reactogenicity of a combined adsorbed tetanus toxoid, low dose diphtheria toxoid, five component acellular pertussis and inactivated polio vaccine in six-year-old children.
    Diez-Domingo J; Delgado JD; Ballester A; Baldó JM; Planelles MV; Garcés M; Graullera M; Ubeda MI; Sánchez F; Sánchez MM; Azor E; Cabrera A; López F; Alvarez M; San-Martín M; González A; Boisnard F; Thomas S
    Pediatr Infect Dis J; 2005 Mar; 24(3):219-24. PubMed ID: 15750457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single doses of diphtheria-tetanus-pertussis and poliomyelitis vaccines are sufficient to generate a booster-type response to tetanus in most migrant children.
    Fougère Y; El Houss S; Suris JC; Rouvenaz-Defago S; Miletto D; Von der Weid L; Willen F; Williams-Smith JA; Gehri M; Crisinel PA
    Vaccine; 2019 Oct; 37(43):6441-6446. PubMed ID: 31522805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.